- Elbit Systems Ltd (NASDAQ:ESLT) reported fourth-quarter FY22 revenue of $1.51 billion, a slight increase of 0.81% year-over-year, beating the consensus of $1.49 billion.
- Adjusted gross profit was $387.8 million, compared to $381.1 million in 4Q21, and the margin was 25.7%, up by 25 bps.
- Adjusted operating income was $103.1 million, compared to $120.1 million a year ago, and the margin was 6.8%, down from 8% in 4Q21.
- Adjusted EPS fell to $1.68 from $2.14 a year ago, missing the consensus of $1.86.
- Elbit System’s net cash provided by operating activities for the fiscal totaled $240.07 million, compared to cash provided of $416.93 million a year ago.
- As of December 31, 2022, the backlog of orders totaled $15.1 billion, ~75% of the current backlog is attributable to orders from outside Israel.
- Dividend: ESLT declared a dividend of $0.5 per share for the fourth quarter, payable on May 1, 2023, to the shareholders of record date on April 18, 2023.
- The company stated that its 2022 financial results reflect global supply chain disruptions and labor cost inflation. They have accelerated investment in a range of operational initiatives to improve performance.
- Price Action: ESLT shares are trading lower by 1.21% at $176.20 premarket on Tuesday.
Why Proteomics Solutions Provider Olink’s Shares Are Rocketing Today
Olink Holding AB (NASDAQ: OLK) shares are trading higher by over 65% after Thermo Fisher Scientific Inc (NYSE: TMO) announced a deal to acquire the company for about $3.1 billion,
